Skip to Content

Search providers like Google and Yahoo! were able to ride out the dot-com bust partly because they discovered one of the Web’s few indisputably successful business models: paid placement of ads, which are commonly displayed atop or alongside unpaid search results in response to a given keyword or phrase. Given that Web users have demonstrated an insatiable demand for pornography and information about the latest health fads and miracle cures, one can’t really blame the search companies for including ads from porn sites and fly-by-night Internet pharmacies. But recently, as the Washington Post and the New York Times report, search engines have started to crack down, on the drugs if not the sex.

Whether driven by pangs of conscience, pressure from the legitimate pharmaceutical industry, or the threat of Congressional investigations, Overture Services – a supplier of keyword-based ads to Yahoo, MSN, and other search sites – said last month it would stop accepting ads from Internet pharmacies, at least until it can figure out how to tell the difference between legitimate and unlicensed drug suppliers. (Overture was recently acquired by Yahoo!.) Yesterday, Google followed suit.

But the big Internet destinations may more than make up for any lost revenue, the papers report, by, in essence, selling access to their users to sex-ad brokers. Since October, users entering sexual search term at AOL have been served a link to Adult Search Fantasy Finder, a porn listings service that pays for traffic from AOL.MSN has long had a similar arrangement with a porn search service called Nightsurf. And although Yahoo! stopped taking porn advertising in 2001, its acquisition of Overture means that it now controls the Overture-owned search engines AlltheWeb and AltaVista, which both accept sexually related ads.

Should we be shocked that search firms are finding more ways to make money from porn? Not at all – so do some of the nation’s biggest media conglomerates and hotel chains. The far bigger surprise is that Overture and Google would voluntarily turn away from their usual “caveat emptor” philosophy and try to protect their users from ads that Congress or big pharma deem pernicious.

Deep Dive

Uncategorized

Embracing CX in the metaverse

More than just meeting customers where they are, the metaverse offers opportunities to transform customer experience.

Identity protection is key to metaverse innovation

As immersive experiences in the metaverse become more sophisticated, so does the threat landscape.

The modern enterprise imaging and data value chain

For both patients and providers, intelligent, interoperable, and open workflow solutions will make all the difference.

Scientists have created synthetic mouse embryos with developed brains

The stem-cell-derived embryos could shed new light on the earliest stages of human pregnancy.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.